Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in IPO/Stock Watch

Hrain Biotech Plans $352 Million Shanghai STAR IPO for Novel CAR Candidates
Beijing's AIM Vaccines Nets $10 Million in Small Hong Kong IPO
YishengBio Announces Merger with NASDAQ SPAC Company at $834 Million Value
Xuanzhu Biopharm, a Sihuan Subsidiary, Files to Raise $345 Million in Shanghai STAR IPO
Apollomics, a US-China Biopharma, will Merge with SPAC to List on NASDAQ Exchange
ChinaBio Event
Singapore and Digital
April 26-27, 2023
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China